Aspen Pharma do Brasil to invest in factory and does not rule out acquisitions in 2016
Aspen Pharma do Brasil vai investir em fábrica e não descarta aquisições para 2016
Intel ID : 225795
Synopsis |
Aspen Pharma do Brasil, a subsidiary of South Africa-based Aspen Pharmacare (SJ:APN) with headquarters in Rio de Janeiro, will invest BRL 200m in factory Serra, in Espírito Santo state, in the next five years, as published by Valor Econômico on 1 June 2015, quoting company's CEO. The investment will be used to double the unit's size and its storage capacity. According to Aspen Pharma do Brasil's CEO, Alexandre Françam "as of next year, Aspen will continue to look at possible acquisition opportunities, but also intends to launch products developed at its units". In addition, he says "this is maybe the big change with respect to previous years".
(content in portuguese)
A Aspen Pharma do Brasil, subsidiária da sul-africana Aspen Pharmacare (SJ:APN) e com sede no Rio de Janeiro, vai investir BRL 20m na fábrica de Serra, no estado do Espírito Santo, nos próximos cincos anos, publicou o Valor Econômico em 1 de junho de 2015, citando à um executivo da empresa. O investimento será utilizado para quase duplicar a unidade, e também, na capacidade de armazenagem da empresa farmacêutica no Brasil. De acordo com o Executivo da Aspen Pharma do Brasil, Alexandre Françam "a partir do próximo ano, a Aspen continua olhando possíveis compras, mas também pretende lançar produtos desenvolvidos em seus centros". Além disso, ele resalta, "Essa talvez seja a grande mudança em relação aos anos anteriores". |
Intel ID | 225795 | |
Value | EUR 5,70m | |
Native Currency |
Brazilian Real (BRL)
Exchange Rate: ![]() |
|
Date |
![]() |
|
Country | ![]() |
|
Region | ||
Continent | ![]() |
|
Geography | ![]() |
|
Subsector (Old TTR Sectors) |
|
|
Type |
![]() |
|
Intel Grade |
![]() |
|
Source |
![]() |
|
Tags | ![]() |
Bidder
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Ultimate Owner (Buyer)
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.